Here are four key trends:
• The market is estimated to grow to a value of around $2.5 billion by 2019.
• The market was valued at $1.7 billion in 2014.
• It is expected to grow at a compound annual growth rate of 7.7 percent from 2014 to 2019.
• The changing preference from mechanical implants to biological ones among the population as well as the rising levels of awareness regarding orthobiologics are the driving forces of this market.
More articles on devices:
aap Implantate ends biomaterials line sale negotiations — 5 things to know
5 things to know about X-spine’s newly-launched Irix-A
Government won’t join qui tam action against MiMedx — 6 key concepts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
